Stock listing

Palvella Therapeutics, Inc.

Selected listing: PI6 · TRADEGATE · EUR · DE

Palvella Therapeutics, Inc. (Tradegate:PI6), Health Technology. Latest release Sep 28, 2026: U.S. Food and Drug Administration Awards Additional Funding…

PI6:TRADEGATEEURDEUpdated October 2, 2026

Ticker: Tradegate:PI6
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Tradegate
Currency: EUR

Latest news from Palvella Therapeutics, Inc.

U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

September 28, 2026

Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences

September 2, 2026

Palvella Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

August 5, 2026

Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

August 4, 2026

Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing

July 29, 2026

All Palvella Therapeutics, Inc. news →

Events

Replays

Palvella Therapeutics, Inc. (PVLA) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 08:30 AM ET
Watch
Palvella Therapeutics, Inc. (PVLA) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:30 AM ET
Watch
Palvella Therapeutics, Inc. (PVLA) Q4 2025 Earnings Call
Tue, Mar 31, 2026 · 08:30 AM ET
Watch

Research Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc. company profile

View the public company page for Palvella Therapeutics, Inc. on 6ix.

Palvella Therapeutics, Inc. news

Read company news and market updates connected to Palvella Therapeutics, Inc..

Palvella Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Palvella Therapeutics, Inc..